These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 5991964)
21. Comparative distribution of Baker's antifolate (NSC 139105) in rat tissues after subcutaneous and intravenous injections. Yang BC; Ho DH; Brown NS; Benjamin RS; Bodey GP J Med; 1980; 11(5-6):413-24. PubMed ID: 6962827 [TBL] [Abstract][Full Text] [Related]
22. The effects of ketoconazole on the human fibrosarcoma cell line HT-1080. Shaughnessey EA; Walker MJ; Das Gupta TK Anticancer Res; 1994; 14(2A):513-6. PubMed ID: 8017855 [TBL] [Abstract][Full Text] [Related]
23. [Experimental research on the antineoplastic activity of osaĭin]. Shvarev IF; Tsetlin AL; Nikol'skaia BS; Nikonov GK Vopr Onkol; 1966; 12(3):64-6. PubMed ID: 5991963 [No Abstract] [Full Text] [Related]
24. [Effect of adrenomimetic agents on the antineoplastic activity of thiophosphamide]. Presnova ZhF; Chernov VA Farmakol Toksikol; 1971; 34(4):456-60. PubMed ID: 5003703 [No Abstract] [Full Text] [Related]
25. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
26. [Dosage schedule of new anticancer drugs--evaluation of the use of 3 anticancer drugs in the study of phases 1 and 2]. Saito T; Oira S; Wakui A; Yokoyama M; Himori T Gan No Rinsho; 1971 Aug; 17(8):589-98. PubMed ID: 4328514 [No Abstract] [Full Text] [Related]
27. Attempt to induce tumours by subcutaneous and intraperitoneal administration of Ferridextran (Spofa). Braun A; Kren V Neoplasma; 1968; 15(1):21-7. PubMed ID: 5650628 [No Abstract] [Full Text] [Related]
28. [The potential of rose Bengal treatment for photodynamic therapy of tumors]. Kaplan MA; Nikitina RG; Malygina AI; Romanko IuS; Bozadzhiev LL; Drozhzhina VV; Arkhipova LM; Deev VV; Smakhtin LA Vopr Onkol; 1999; 45(5):557-9. PubMed ID: 10629718 [TBL] [Abstract][Full Text] [Related]
29. Polyclonal lymphocyte activators: adjuvant activity of a crude extract of Streptococcus faecium. Iannello D; Foca' A; Bonina L; Mastroeni P G Batteriol Virol Immunol; 1982; 75(1-6):9-15. PubMed ID: 7187352 [TBL] [Abstract][Full Text] [Related]
30. [The effect of serotonin, 5-fluorouracil and prednisolone on the phagocytic response of neutrophils in rats with sarcoma-45]. Shipovskaia LA; Mal'tseva LF Farmakol Toksikol; 1975; 38(1):77-9. PubMed ID: 1112399 [No Abstract] [Full Text] [Related]
31. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice]. Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889 [TBL] [Abstract][Full Text] [Related]
32. [Effect of dipin on the activity of water soluble adenosine triphosphatase in rats with sarcoma 45]. Presnova ZhF; Chernov VA Farmakol Toksikol; 1968; 31(4):473-6. PubMed ID: 4235234 [No Abstract] [Full Text] [Related]
33. Influence of various administration routes on the antitumor efficacy ofTT-232, a novel somatostatin analog. Tejeda M; Gaal D; Schwab RE; Pap A; Szúts T; Keri G Anticancer Res; 2000; 20(2A):1023-7. PubMed ID: 10810391 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of enrofloxacin in sheep following intravenous and subcutaneous administration. Rahal A; Kumar A; Ahmad AH; Malik JK; Ahuja V J Vet Pharmacol Ther; 2006 Aug; 29(4):321-4. PubMed ID: 16846471 [No Abstract] [Full Text] [Related]
35. Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2. Potapnev MP; Istomin YP; Ismail-zade RS; Zhavrid EA Eksp Onkol; 2004 Mar; 26(1):67-70. PubMed ID: 15112583 [TBL] [Abstract][Full Text] [Related]
36. [Antineoplastic spectrum of mitoxantrone in rat ascitic hepatoma]. Satoh H Gan To Kagaku Ryoho; 1982 Jan; 9(1):26-30. PubMed ID: 7184361 [TBL] [Abstract][Full Text] [Related]
37. [Antitumor activity of phallolysin from Amanita phalloides (author's transl)]. Seeger R; Lehmann D Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(3):235-42. PubMed ID: 4270744 [No Abstract] [Full Text] [Related]
38. Timing may be a critical factor in drug therapy. Hrushesky WJ; Nygaard SD; Young J Cancer Treat Rep; 1987 Dec; 71(12):1321. PubMed ID: 3690550 [No Abstract] [Full Text] [Related]
39. Adsorption of antineoplastic drugs following large-volume ip administration to rats. Litterst CL; Torres IJ; Arnold S; McGunagle D; Furner R; Sikic BI; Guarino AM Cancer Treat Rep; 1982 Jan; 66(1):147-55. PubMed ID: 7053249 [No Abstract] [Full Text] [Related]
40. [Experimental use of antitumor preparations in low doses]. Garkavi LKh; Kvakina EB; Mulatova AK; Taras'iants FM Vopr Onkol; 1981; 27(7):61-6. PubMed ID: 6791380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]